Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.

Luc MaillardAxel de LabriolleCamille BrasseletBenjamin FaurieNicolas DurelFabien de PoliSébastien BosleHend MadiotJacques BerlandLoic Belle

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)

The Cobra PzF stent was safe and effective in routine practice patients and seems feasible in situations when short DAPT or Mono Antiplatelet Therapy (MAPT) is needed. One-year follow-up was associated with satisfactory clinical outcomes and validate previously reported data.

Keyphrases

antiplatelet therapy
end stage renal disease
chronic kidney disease
ejection fraction
acute coronary syndrome
coronary artery disease
percutaneous coronary intervention
coronary artery
clinical practice
machine learning
left ventricular